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ABSTRACT
Objective: The present community-based cross-sectional study was aimed to examine the association of 
metabolic syndrome (MS) with obesity measures, metabolic proﬁ  les, and intake of dietary fatty acids in Asian 
Indian population. Patients and Methods: A total of 350 adult (30 years and above) individuals (184 males 
and 166 females) inhabiting in and around Kolkata, India participated in this study. MS was deﬁ  ned using the 
protocol speciﬁ  cally designed for Asian Indian population. Results: The prevalence of MS in the study was 
31.4%. The prevalence was signiﬁ  cantly higher (P < 0.01) in females (48.2%) as compared to males (16.3%). It 
was observed that males without MS had signiﬁ  cantly higher mean waist circumference (WC P < 0.05); waist–
hip ratio (WHR; P < 0.001); triglyceride (TG; P < 0.05); very low density lipoprotein cholesterol (VLDLc; P 
< 0.05) and fasting blood glucose (FBG; P < 0.01) as compared to females without MS. Signiﬁ  cant differences 
were also observed for dietary intake of total fatty acids (TFA; P < 0.001); saturated fatty acids (SFA; P < 
0.001) and polyunsaturated fatty acids (PUFA; P < 0.001) between individuals with and without MS. However, 
no signiﬁ  cant association was observed in individuals with MS after controlling for age and sex. On the other, 
WC and body mass index (BMI) had signiﬁ  cant correlation with SFA: mono unsaturated fatty acids (MUFA; 
P < 0.01) in individuals without MS even after controlling for age and sex. Conclusion: It seem reasonable 
to argue that while dealing with MS in Asian Indians, clinicians should consider obesity measures, metabolic 
proﬁ  les and dietary fatty acids simultaneously.
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INTRODUCTION
The metabolic syndrome (MS) may be deﬁ  ned as the 
constellation of cardiovascular disease (CVD) risk factors, 
e.g., dyslipidemia, hypertension, hyperglycemia, etc. Persons 
with MS are essentially at twice the risk of CVD compared 
to those without the syndrome. It further raises the risk 
of type 2 diabetes mellitus (T2DM) by about ﬁ  vefold. In 
most countries, about 20–30% of the adult population 
is predisposed to MS.[1] The MS is not a discrete entity 
known to be caused by a single factor. Moreover, it shows 
considerable variation in the components among different 
individuals. This variation is even greater among different 
racial and ethnic groups.[2] The MS is not restricted to 
the adults only, the predisposition of MS however, starts 
much early in life especially during the adolescence and 
young age.[3–7] 
The prevalence of MS is increasing south Asian countries 
including India, leading to increased morbidity and 
mortality due to T2DM and CVD.[8] The increasing 
incidence of MS among the Asian Indians is a reason for 
concern since if effective interventions are not applied.  [9] 
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patterns, including high-saturated fatty acids (SFA) and low 
vegetable intakes, contribute to weight gain and increase 
the risk of metabolic disturbances.[10] Saturated fat intake 
is associated with increased risk of coronary heart disease 
(CHD); the greatest risk reduction is associated with 
poly unsaturated fatty acids (PUFA) followed by mono 
unsaturated fatty acids (MUFA).[11]
In Asian Indians, there existed significant inverse 
association between central obesity measures and intake 
of unsaturated fatty acids due to recent shift in dietary 
habits causing an increase in the prevalence of obesity 
and dyslipidemia in this region.[12,13] Keeping this view in 
mind, the present study was undertaken among the Asian 
Indian population living in the eastern part of India with 
the following objectives: 
•  To compare obesity measures, lipids, lipoproteins, 
plasma glucose, and intake of dietary fatty acids in 
subjects with and without MS.
•  To study the association of dietary fatty acids, their 




The present community based cross-sectional study was 
conducted on adult (aged 30 years and above) Asian 
Indian men and women from Kolkata (erstwhile Calcutta) 
and suburbs, West Bengal, India. A total of 350 individuals 
(184 males and 166 females) participated in the study. 
Subjects were categorized into two groups: individuals 
with MS (n = 110; male = 30, and female = 80) and 
without MS (n = 240; male = 154, and female = 86). 
Pregnant women, women on hormone therapy (HT), and 
individuals with known illness like ischemic heart disease 
(IHD), T2DM, and hypertension were not incorporated 
in the study. Before the actual commencement of the 
study, a public advertisement was circulated regarding 
the study with the help of local municipal council 
ofﬁ  cials. Individuals were selected randomly after they 
responded to the local advertisement. The response rate 
was as high as 85%. The institutional ethics committee 
of the “Human Genetic Engineering Research Centre” 
(HGERC) has had approved the study. Written consent 
was obtained prior to actual commencement of the study.
Anthropometric measures
Height (nearest 0.1 cm), weight (nearest 0.5 kg), waist 
(nearest 0.2 cm), and hip circumferences (nearest 0.2 cm) 
were obtained using standard techniques.[14] The body 
mass index (BMI, kg/m2) and waist–hip ratio (WHR) were 
subsequently computed.
Blood pressure
Left arm systolic (SBP) and diastolic (DBP) blood pressure 
measurements was twice taken using sphygmomanometer 
and stethoscope and was averaged for analyses. A third 
measurement was taken only when the difference between 
the two measurements was ≥5 mmHg. A 5 min relaxation 
period between measurements was maintained through 
out the study. SBP and DBP was measured as appearance 
(phase I) and disappearance (phase V) of Korotkoff sound, 
respectively.
Metabolic proﬁ  les
A fasting blood sample (7 mL) was drawn from participants 
for the determination of fasting plasma glucose (FBG), 
total cholesterol (TC), triglyceride (TG), and high density 
lipoprotein cholesterol (HDLc). All subjects were 
maintained an overnight fast of ≥12 h prior to blood 
collection. Plasma was separated within 2 h of blood 
collection using a microcentrifuge at 1000 rpm for 20 min in 
room temperature. Estimation of FBG, TC, TG, and HDLc 
were carried out using an ERBA Microscan ELISA Reader 
(Trans Asia Biomedicals Limited, Mumbai, India). Low-
density lipoprotein cholesterol (LDLc) and very low-density 
lipoprotein cholesterol (VLDLc) was then calculated using 
the standard formulas: LDL = TC – (HDL + TG/5) and 
VLDL = TG/5. All metabolic proﬁ  les were estimated 
in mg/dL (mg %) unit. TC:HDLc ratio was calculated 
subsequently. The reproducibility of the instruments was 
checked periodically using control solutions.
Dietary fatty acids
The dietary intake was recorded using the 24 h recall 
method for seven consecutive days using a food frequency 
schedule prepared in local language. The total fatty acids 
(TFA), saturated fatty acids (SFA), monounsaturated fatty 
acids (MUFA), and polyunsaturated fatty acids (PUFA) 
contents of various foods were obtained using the standard 
guidelines.[15] The standardization to convert foodstuffs in 
to fatty acids has been mentioned elsewhere.[12,13,16,17]
Deﬁ  nition of metabolic syndrome
Subjects with any three or more of the following criteria 
were considered under MS:[18]
•  Waist circumference (cm): male > 90; female > 80 
• Triglycerides  (mmol/L):  ≥ 2.25
•  HDLc (mmol/L): male < 1.03; female < 1.28Das, et al.: Metabolic syndrome and dietary fatty acids
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•  Blood pressures (mmHg): SBP ≥ 130 and/or DBP ≥ 85
•  Fasting blood glucose (FBG) (mmol/L): ≥ 5.56
Statistical analysis
Descriptive statistics such as mean and standard deviation 
(SD) of anthropometric, obesity measures, metabolic 
proﬁ  les, and intake of dietary fatty acids were undertaken 
separately for each group (metabolic vs. non-metabolic) 
and sex. Person’s partial correlation (adjusted for age and 
sex) between obesity measures (WC and BMI) and dietary 
fatty acids was also undertaken. All statistical analyses 
were performed using SPSS (PC+ version 10). A statistical 
signiﬁ  cance (two-tailed) was set at P < 0.05.
RESULTS
The prevalence of MS in the present population was 
31.4%. The prevalence was signiﬁ  cantly higher (P < 0.01) in 
females (48.2%) as compare to males (16.3%). The analysis 
of variance (ANOVA) showed a signiﬁ  cantly higher mean 
WC (P < 0.001); WHR (P = 0.001); TC (P < 0.001); TG 
(P < 0.001); VLDLc (P < 0.001); TC:HDLc (P = 0.05) 
and FBG in males with MS as compared to females with 
MS [Table 1]. 
However, males without MS had signiﬁ  cantly higher mean 
WC (P < 0.05); WHR (P < 0.001); TG (P < 0.05); VLDLc 
(P < 0.05), and FBG (P < 0.01) as compared to females 
without MS [Table 2]. 
Comparison of dietary intake of fatty acids (g/week) 
between males and females with and is presented in Table 
3. It was observed that males with MS had a signiﬁ  cantly 
higher consumption of MUFA (P < 0.01) and TFA:SFA 
(P < 0.001), whereas females with MS had signiﬁ  cantly 
Table 1: Obesity measures , metabolic proﬁ  les, and blood pressures variables between males and females with 
metabolic syndrome (n = 110) 








Age (years)* 56.67 ± 13.12  51.77 – 61.57 51.81 ± 10.39 49.50 – 54.12
BMI (kg/m2) 24.71 ± 2.93  23.6 – 25.80   24.32 ± 3.61  23.52 – 25.12
WC (cm)*** 96.83 ± 5.77  94.68 – 98.99   92.98 ± 6.72 91.48 – 94.47
WHR*** 1.01 ± 0.003  0.99 – 1.02  0.97 ± 0.004  0.95 – 0.97
TC (mmol/L) ***  2.42 ± 0.41   2.27 – 2.58  2.23 ± 0.26 2.17 – 2.29
TG (mmol/L) ***   1.82 ± 0.37  1.68 – 1.96  1.65 ± 0.24 1.60 – 1.71
HDLc (mmol/L)  1.06 ± 0.13   1.01 – 1.12 1.10 ± 0.11  1.08 – 1.13
LDLc (mmol/L) ***  3.64 ± 0.88   3.30 – 3.97 3.23 ± 0.59  3.09 – 3.36
VLDLc (mmol/L) *** 0.36 ± 0.007  0.33 – 0.39 0.33 ± 0.004 0.32 – 0.34
TC:HDLc*** 2.32 ± 0.566  2.11 – 2.54  2.04 ± 0.39 1.96 – 2.13
FBG (mmol/L) ***  6.46 ± 2.14 5.67 – 7.26  5.22 ± 1.17 4.96 – 5.48
SBP (mmHg) 145.57 ± 23.41 136.83 – 154.31 149.19 ± 21.69 144.36 – 154.01
DBP (mmHg) 88.43 ± 9.13  85.02 – 91.84 87.71 ± 9.02 85.71 – 89.72
CI =Conﬁ  dence interval; values are mean ± standard deviation.BMI = Body mass index; WC = waist circumference; WHR = waist–hip ratio; TC = total cholesterol; TG = 
triglyceride; HDLc = high density lipoprotein; LDLc = low density lipoprotein; VLDLc = very low density lipoprotein; FBG = fasting plasma glucose; SBP = systolic blood 
pressure; DBP = diastolic blood pressure. Signiﬁ  cant sex difference at *P < 0.05; **P < 0.01; ***P < 0.001.
Table 2: Obesity measures, metabolic proﬁ  les, and blood pressures variables between males and females without 
metabolic syndrome (n = 240)
Variables   Male  (n = 154)  95% CI Lower–upper Female (n = 86) 95% CI Lower–upper
Age (years)*** 53.53 ± 12.24 51.58 – 55.47 45.38 ± 11.80 42.85 – 47.91
BMI (kg/m2) 21.91 ± 4.13 21.25 – 22.56 22.15 ± 4.75 21.13 – 23.17
WC (cm)* 88.44 ± 10.13  86.83 – 90.05 85.12 ± 10.50 82.86 – 87.37
WHR*** 0.96 ± 0.006 0.95 – 0.97 0.92 ± 0.005  0.91 – 0.93
TC (mmol/L) 2.28 ± 0.28  2.23 – 2.32 2.24 ± 0.24 2.19 – 2.30
TG (mmol/L)* 1.57 ± 0.27  1.53 – 1.61 1.49 ± 0.23 1.44 – 1.54
HDLc (mmol/L) 1.15 ± 0.12  1.13 – 1.17 1.16 ± 0.12 1.14 – 1.19
LDLc (mmol/L) 3.34 ± 0.65 3.23 – 3.44 3.28 ± 0.58 3.16 – 3.41
VLDLc (mmol/L)* 0.31 ± 0.005 0.30 – 0.32 0.29 ± 0.004 0.28 – 0.30
TC:HDLc 2.02 ± 0.44 1.95 – 2.09 1.96 ± 0.37 1.87 – 2.04
FBG (mmol/L) ** 4.92 ± 0.88 4.78 – 5.06 4.64 ± 0.51 4.53 – 5.75
SBP (mmHg) 130.52 ± 23.43  126.79 – 134.25 126.07 ± 21.65 121.43 – 130.71
DBP (mmHg) 81.01 ± 11.44 79.19 – 82.83 79.55 ± 10.39  77.32 – 81.77
Values are mean ± standard deviation. Signiﬁ  cant sex difference at *P < 0.05; **P < 0.01; ***P < 0.001.Das, et al.: Metabolic syndrome and dietary fatty acids
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higher rate of proportion of SFA:MUFA (P < 0.01) and 
SFA:PUFA (P < 0.001) consumption than their male 
counterparts.
However, males without MS had significantly higher 
proportion of TF:SFA (P < 0.001) consumption than 
their female counterparts. Whereas females without MS 
had signiﬁ  cantly higher SFA (P < 0.005) and SFA:MUFA 
(P < 0.001) consumption as compared to males without 
MS [Table 4].
Pearson’s partial correlations (controlling for age and 
sex) between adiposity (WC and BMI) and dietary fatty 
acids are presented in Table 5. It was observed that WC 
had signiﬁ  cant correlation with SFA (P < 0.01); MUFA 
(P < 0.05) as well as TF:SFA (P < 0.01); SFA:MUFA (P 
< 0.01), and SFA:PUFA (P < 0.01). BMI had signiﬁ  cant 
correlation with SFA (P < 0.05) and TFA:SFA (P < 
0.05). However, no signiﬁ  cant association was observed 
in individuals with MS after controlling for age and sex. 
On the other, WC and BMI had signiﬁ  cant correlation 
with SFA:MUFA (P  < 0.01) in individuals without MS.
DISCUSSION
Our ﬁ  ndings hinted that intake of saturated fat may be 
a major risk factor for the onset of MS in adult Asian 
Indians. Moreover, it appears that not the total fat but 
the amount of saturated fat consumed in association with 
TFA:SFA, SFA:MUFA, and SFA:PUFA was adversely 
affecting the adiposity level, lipids, blood pressures, 
and blood glucose levels in this population and in turn 
cumulatively enhancing the possibility to predispose to 
MS phenotypes.
Table 3: Dietary fat intake (g/week) by males and females with metabolic syndrome (n = 110)
Variables  Male (n =30)  95% CI Lower–upper Female (n = 80) 95% CI Lower-upper
TF 615.78 ± 75.46  587.6 – 643.9 586.23 ± 74.53 569.6 – 602.8
SFA 190.43 ± 38.58 176.0 – 204.8 195.82 ± 27.68 189.6 – 201.9 
MUFA** 228.60 ± 27.00  218.5 – 238.6 213.72 ± 25.65 208.0 – 219.4
PUFA 159.09 ± 25.76 149.4 – 168.7 153.82 ± 26.79 125.6 – 182.0
TF:SFA*** 3.30 ± 0.35 3.13 – 3.47 3.01 ± 0.26  2.9 – 3.0
SFA:MUFA*** 0.83 ± 0.11 0.78 – 0.87 0.91 ± 0.10 0.89 – 0.94
SFA:PUFA*** 1.21 ± 0.25 1.12 – 1.31 1.41 ± 0.26 1.35 – 1.47
PUFA:MUFA 0.69 ± 0.009 0.66 – 0.73 0.72 ± 0.006 0.58 – 0.86
Values are mean ± standard deviation. TF = Total fat; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids. Signiﬁ  cant sex 
difference at *P < 0.05; **P < 0.01; ***P < 0.001.
Table 4: Dietary fat intake (g/week) by males and females without metabolic syndrome (n=240)
Variables  Male (n = 30)  95% CI Lower–upper Female (n = 80) 95% CI Lower–upper
TF 560.09 ± 67.29 549.3 – 570.8 561.30 ± 71.36 546.0 – 576.6
SFA* 146.06 ± 20.18 142.8 – 149.2 152.47 ± 22.89 147.5 – 157.3
MUFA 215.33 ± 18.11 212.4 – 218.2 213.32 ± 19.47 209.1 – 217.5
PUFA 157.26 ± 34.59 151.7 – 162.7 153.47 ± 32.23 146.5 – 160.3
TF:SFA*** 3.85 ± 0.28 3.80 – 3.89 3.70 ± 0.26 3.6 – 3.7
SFA:MUFA*** 0.67 ± 0.006 0.66 – 0.68 0.71 ± 0.007 0.69 – 0.73
SFA:PUFA 1.00 ± 0.75 0.88 – 1.12 1.02 ± 0.20 0.97 – 1.06
PUFA:MUFA 0.72 ± 0.12 0.70 – 0.74 0.71 ± 0.11 0.69 – 0.47
Values are mean ± standard deviation. Signiﬁ  cant sex difference at *P < 0.05; **P < 0.01; ***P < 0.001.
Table 5: Partial correlation (controlling for age and sex) between dietary fatty acids and adiposity measures
Correlation TFA SFA MUFA PUFA TF:SFA SFA:MUFA SFA:PUFA PUFA:MUFA
Total population (n = 350)
WC –0.92 0.207** 0.133* –.571 –205** 0.177** 0.116* –0.088
BMI 0.03 0.117* 0.081 –.056 –.133* 0.096 0.054 –0.076
Individuals with metabolic syndrome (n = 110)
WC 0.128 0.045 0.124 –.139 0.107 –0.053 –0.012 –0.158
BMI 0.003 –0.080 –0.003 –.103 0.164 –0.110 –0.069 –0.102
Individuals without metabolic syndrome (n = 240)
WC –.001 –.036 0.118 –.027 0.060 –0.165** 0.031 –0.108
BMI –.035 –.082 0.097 –.037 0.082 –0.214** –0.016 –0.107
Signiﬁ  cant at *P < 0.05; **P < 0.01.Das, et al.: Metabolic syndrome and dietary fatty acids
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The gender differences in prevalence of MS have been 
found in several other studies also.[3,19] It might be due 
to different cut-off points set as criteria for MS like WC 
and HDLc. It is important to mention that individuals 
with impaired glucose tolerance, impaired fasting glucose 
was observed more frequently in men whereas impaired 
glucose tolerance occurred relatively more often in women.
[16,17] Lipids accumulation patterns differ between women 
and men. Premenopausal women more frequently develop 
peripheral obesity with subcutaneous fat accumulation 
whereas men and postmenopausal women are more prone 
to central or android pattern of obesity. In particular, 
android obesity is associated with increased cardiovascular 
mortality and the development of T2DM. Inﬂ  ammation 
increases cardiovascular risk particularly in women. It has 
also been mentioned that the pathophysiology of the MS, 
and its contribution to the relative risk of cardiovascular 
events and heart failure show gender differences, which has 
immense potential relevance for prevention, diagnostics, 
and therapy of the syndrome.[20]
Certain dietary patterns, including high SFA and low 
vegetable intake, contribute to weight gain and increase the 
risk of metabolic disturbances, whereas such potentially 
modiﬁ  able lifestyle factors may reduce cardiovascular risk.
[10,21] In a recent study from India revealed that increased 
dietary ω-6 PUFA and saturated fat intake are signiﬁ  cantly 
associated with fasting hyperinsulinemia and subclinical 
inﬂ  ammation, respectively, and might be responsible for 
the increasing prevalence of insulin resistance, the MS 
and T2DM in Asian Indians.[8,9,16,22] In another study, it 
was found that the dietary total fat may increase whereas 
linoleic acid intake may reduce the risk of MS in Japanese 
descendants living in Brazil.[23] Study from the United 
Arab Emirates (UAE) pointed out that poor dietary habits 
including consumption of high-energy foodstuffs, diets 
high in total carbohydrates, fat, and simple sugars were 
associated with MS.[24] In a multiethnic study (comprising 
of African-Americans, Whites and Hispanics) on healthy 
children aged 7–12 years revealed that diet composition 
was more closely related to the components of the MS 
than was physical activity, with carbohydrate intake being 
adversely related to WC, TG levels, and glucose levels. 
Moreover, relationships among diet and MS outcomes were 
stronger among African-American children[25] reﬂ  ecting 
ethnic variation. Our ﬁ  ndings of an adverse impact of 
TFA:SFA intake and inverse relation of adiposity with 
PUFA, i.e., protection of polyunsaturated fat concerning 
the association with MS is in accordance with the ﬁ  nding 
of several other investigations.[23,26-29]
However, the major limitation was that the study was 
performed on a relatively small sample size and therefore 
not representative of Asian Indian population. Moreover, 
the dietary fatty acids were obtained through retrospective 
method and not directly from the isolated plasma. Further 
prospective studies are required to better compared gene-diet 
interaction 30 in the growing menace of MS in this part of 
the world. 
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